Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03440957
Other study ID # 69HCL17_0723
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 21, 2018
Est. completion date February 2, 2020

Study information

Verified date July 2022
Source Hospices Civils de Lyon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Staying confined in the bed is frequent at the end of life. The cancer patients can also experiment this situation, and consequences are painful, with pain increasing with the time. This pain are related to the joints stiffing , muscles mass decreasing, and tendons retractions . The non pharmacological approach associated with the conventional treatments can be interesting to assess in this frails patients.


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date February 2, 2020
Est. primary completion date February 2, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Man or woman - Aged 18 years or older - Having signed informed consent to participate in the study - Patient affiliated to a social security scheme - Patient with pain affecting the musculoskeletal system following prolonged bed rest - Capable to understand French - Capable of completing self-assessment scales Exclusion Criteria: - Patients with bone metastases at risk for the use of osteopathy - Patients under legal protection measures - Patients with cognitive impairment preventing self-evaluation - Patient who is considered too fragile or with a clinical condition too unstable by the doctor refer to be included in the study - Patients in the pre-agonic or agonic phase

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Osteopathic treatment
The patients meeting the inclusions criteria will be informed of the study and an osteopathic treatment holistic ,involving all the body will be applied, three time with 2 days between the treatments .Each meeting with the practitioner will last around 40 minutes. The pain and symptoms assessment will be done before and after the treatment .

Locations

Country Name City State
France Hôpital Lyon Sud Pierre-Bénite

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Decreased pain intensity of 2 points measured by Analog Visual Scale (AVS) before and after the session 15 days
Secondary Decrease in analgesic consumption for pain related to immobilization 15 days
Secondary Decreased 2 points of intensity of other symptoms associated before and after session measured with Edmonton Symptom Assessment System (ESAS). 15 days